You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHL

Showing 626 - 650 of 1,420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Milano, MI, Italy
    Ospedale San Raffaele
Apr 2, 2022

Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

Completed
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 16, 2021

Chronic Lymphocytic Leukemia Trial in Cologne (lenalidomide, Placebo)

Completed
  • Chronic Lymphocytic Leukemia
  • Cologne, Germany
  • +1 more
Dec 16, 2021

Study of Lymphoma in Asia

Completed
  • Lymphoma, Follicular
  • +5 more
    • Hexi District, China
    • +3 more
    Nov 24, 2020

    Associated With Occupational Exposure to Trichloroethylene

    Completed
    • Industrial Hygiene
    • +2 more
      • Guangzhou, China
        Guangdong National Poison Control Center (NPCC)
      Oct 30, 2020

      IMPACT Non Hodgkins Lymphoma (NHL) Study

      Completed
      • Non-Hodgkin's Lymphoma
      • No intervention
      • (no location specified)
      Jul 4, 2018

      Lymphoma Trial in Minneapolis (drug, procedure, radiation, biological)

      Completed
      Has Results
      • Lymphoma
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Jul 10, 2020

      Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

      Recruiting
      • Multicentric Castleman Disease
      • Lilongwe, Malawi
        UNC Project, Kamuzu Central Hospital
      May 2, 2022

      The Potential of Patient-reported Outcome Measures in Detection

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Patient Reported Outcome
      • No intervention
      • Copenhagen, Denmark
        Therese Lassen
      Mar 18, 2022

      DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • San Juan, Puerto Rico
        Auxilio Mutuo Cancer Center
      Jan 19, 2023

      Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

      Recruiting
      • Lymphoma, Follicular
      • Follicular Lymphoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 14, 2022

      Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Shanghai (Methotrexate, Etoposide, Dexamethasone)

      Active, not recruiting
      • Extranodal NK/T-cell Lymphoma, Nasal Type
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Aug 19, 2021

      Lymphoma Trial in Germany, Spain, United States (cemiplimab, REGN1979)

      Active, not recruiting
      • Lymphoma
      • Santa Monica, California
      • +21 more
      Sep 20, 2021

      Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

      Recruiting
      • Marginal Zone Lymphoma
      • Zhengzhou, Henan, China
        Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
      Aug 15, 2021

      Primary Vitreoretinal Lymphoma Trial in Beijing (Methotrexate, Rituximab, Zanubrutinib)

      Recruiting
      • Primary Vitreoretinal Lymphoma
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 19, 2021

      Lymphoma Trial in Worldwide (cyclophosphamide, cytarabine, dexamethasone)

      Completed
      • Lymphoma
      • Vienna, Austria
      • +9 more
      May 24, 2022

      Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)

      Completed
      Has Results
      • Follicular Lymphoma
      • Diffuse Large B-Cell Lymphoma
      • Los Angeles, California
      • +40 more
      Feb 20, 2020

      AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

      Completed
      Has Results
      • AIDS-related Diffuse Large Cell Lymphoma
      • +8 more
      • Eldoret, Kenya
      • +1 more
      Sep 12, 2022

      Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

      Active, not recruiting
      • Multiple Myeloma
      • +5 more
      • Duarte, California
      • +38 more
      Aug 18, 2022

      Primary CNS Lymphoma Trial in Beijing (orelabrutinib, Sintilimab, Tislelizumab)

      Recruiting
      • Primary Central Nervous System Lymphoma
      • Beijing, Beijing, China
        Wei Zhang
      May 19, 2021

      CAR Trial in Hefei (CD19/CD20 CAR-T cell infusion)

      Recruiting
      • CAR
      • CD19/CD20 CAR-T cell infusion
      • Hefei, Anhui, China
        Anhui Provincial Hospital
      Mar 4, 2021

      Relapsed and/or Refractory Acute Lymphoblastic Leukemia, Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma Trial in

      Not yet recruiting
      • Relapsed and/or Refractory Acute Lymphoblastic Leukemia
      • Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma
      • CD79b CAR-T Cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Oct 23, 2020

      Lymphoma, Large B-Cell, Diffuse, Transplantation, Chemo Trial in Shanghai (PD-1 Inhibitor Tislelizumab maintenance therapy)

      Not yet recruiting
      • Lymphoma, Large B-Cell, Diffuse
      • +2 more
      • PD-1 Inhibitor Tislelizumab maintenance therapy
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Mar 15, 2021

      Follicular Low Grade Non-Hodgkin's Lymphoma Trial (G100, Pembrolizumab, Rituximab)

      Terminated
      Has Results
      • Follicular Low Grade Non-Hodgkin's Lymphoma
      • (no location specified)
      Aug 20, 2020

      Systemic Lupus Erythematosus Trial in Worldwide (Baricitinib, Placebo)

      Completed
      • Systemic Lupus Erythematosus
      • Gilbert, Arizona
      • +158 more
      Nov 29, 2021